Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
DRD1 Biologics Sequence Review Report 2026: D(1A) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CNR2 Biologics Sequence Review Report 2026: Cannabinoid receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CNR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CMKLR2 Biologics Sequence Review Report 2026: Chemerin-like receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CMKLR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB1 Biologics Sequence Review Report 2026: Acetylcholine receptor subunit beta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNG Biologics Sequence Review Report 2026: Acetylcholine receptor subunit gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB2 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CASR Biologics Sequence Review Report 2026: Extracellular calcium-sensing receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CASR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA7 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-7 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA5 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IGF1R Biologics Sequence Review Report 2026: Insulin-like growth factor 1 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IGF1R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
13
14
15
16
17
>>
1103
>